IT systems · Practical guide

Validating R: testing packages, data and analyses

An R script may produce a plausible mean despite a missing sample, a package loaded from another library or an analysis that cannot be repeated later. Trace data, code and environment together. The calculation example shows where independent expected results and existing evidence can establish more than a successful script run.

Table of contents

At a glance

What does it mean to validate R for GMP use?

Demonstrate that a defined R analysis, with its data, scripts, packages and operating conditions, is fit for its intended use. Define the analytical purpose and testable expectations. Assess developer evidence, test relevant data and failure cases, and preserve the link between inputs, code and result. An installable package, lockfile or identical report demonstrates only a limited part of the overall suitability.

  • The subject of evaluation is the specific analysis together with its dependencies, not the product name R alone.
  • Base R, Recommended Packages, and additional packages have different source and traceability boundaries.
  • A plausible mean can mask missing or duplicate data sets.
  • Reproducibility, statistical suitability of the method, and controlled storage are distinct responsibilities.

First clarify: Which decision is supported by your analysis?

Describe the pathway from data entry to use in the process. Does R calculate a trend for quality assessment, process test data, or serve for non-binding exploration? Crucially, what are the implications if a report is incorrect, incomplete, or not traceable? A later-used export falls within this consideration, even if the final decision is made outside of R.

This guide addresses the use within the human medicinal product GMP environment. Annex 11 is a GMP guideline for computerized systems; the current EudraLex version still references the revision from January 2011. Clinical trials, medical devices, and US requirements require separate evaluation. A document with an FDA reference in the filename does not constitute official approval of a clinical or GMP application.

Define the purpose so specifically that a specialist responsible for quality can assess the outcome: Which population, units, time periods, and exclusions apply? Who is authorized to use the report? This defines requirements for data, calculations, and supporting evidence. A general category or fixed test number from the name R would be too coarse for this level of specificity.

Sources: [7] [8] [2]

Separate R, add-on packages, and development interface

R is a free environment for statistical computing and graphics. The version referenced in this document is R 4.6.1, released on 24 June 2026. A development interface can facilitate writing and execution, but it is not equivalent to the R runtime. Document the actual combination in use, including the operating system, relevant packages, and execution pathway.

The R-Foundation document dated 12 March 2026 is directed at regulated clinical study environments and addresses official distribution using Base R and Recommended Packages. Other add-on packages are explicitly excluded from the scope of this document. Publication on CRAN or by a recognized author does not extend the scope defined herein. Therefore, for any additional functions utilized, appropriate package-specific information is required. This document serves as a general orientation only and does not constitute validation evidence for specific applications in GMP settings.

Arrange the documents to the functions actually used. A documented development and test practice can be taken over meaningfully; it does not have to be re-examined completely without reason. It remains open whether the concrete version, configuration and use in the process are covered. These gaps determine your supplementary tests, not the mere number of installed packages.

Sources: [1] [2] [8]

Capture the executable environment, not just a version number

R can load packages from different library directories. Site and user libraries, as well as search paths, influence the available package inventory. For compiled packages, additional considerations such as compilers and external libraries may also be relevant. Therefore, two computers running the same version of R are not necessarily equivalent analytical environments.

renv supports project-specific package libraries and a lockfile. The tool captures the R version but does not manage R itself. Operating system libraries, compilers, or external tools are not fully provided. Use a lockfile as part of your validation evidence and specifically verify that the intended recovery pathway actually functions.

The following internal matrix assists in defining scope. Not every row requires a separate document. It aims to prevent a relevant component from being lost between development and operations. Meaning in the process determines how precisely a particular element is documented and verified.

Preparing for a controlled analysis in R
ComponentFixed referenceQuestion to test
R-Run time Version, Platform and Implementation Path Does the planned code run in the intended environment?
Packages Versions, source repositories and library paths Is the expected package quantity loaded?
External Dependencies Required libraries or tools Are these available upon restoration?
Script and Parameters Unique status and professional specifications Was this run included in the approved analysis?
Inputs Data version, structure, and origin Is the expected dataset complete?
Outputs Result, protocol, and storage location Is the relationship later understandable?

Sources: [3] [4]

Import rules affect the calculation the process relies on

A file can be successfully read and yet misinterpreted. R functions such as read.table and its CSV variants include parameters for delimiters, decimal markers, missing values, and column types. If these do not align with the data specification, the interpretation of the input may change prior to any actual statistical analysis.

Test known normal data alongside deliberately unexpected inputs, including a text column, a missing sample value, an extra row and a duplicate key. Decide in advance when the process should reject an error, allow a controlled conversion or refer the case for review. An automatic repair can change the meaning of the data.

Even erroneous values require a justified rationale. In the mean function, the na.rm parameter determines whether missing values are removed prior to calculation; the default is FALSE. Setting it to TRUE may be computationally convenient, but it does not substitute for a statement on data completeness. Ensure that the result clearly indicates how many values were expected, utilized, and excluded, and provide a justification for each.

Sources: [5] [6] [8]

Evaluate method, script, and results separately

A correctly implemented algorithm may be inappropriate for the specific scientific question. Conversely, a suitable method in the script may be incorrectly parameterized. Therefore, evaluate the method selection from a scientific standpoint and subsequently verify its specific implementation: units, filters, grouping, rounding, exclusions, and interpretation of the results.

For a simple deterministic calculation, an independently derived target value is appropriate. For more complex statistical methods, appropriate reference datasets, analytically known properties, or justified comparison methods may be required. A second script is only beneficial if it does not simply replicate the same errors. The desired level of agreement must be suitable for the calculation.

Consider also the preparation of the report. A table may display the correct internal value in the wrong unit or under the incorrect sample name. Therefore, verify the professionally used endpoint. These work aids do not prescribe a universal testing method; they are intended to make the relevant consequences of errors in your analysis visibly apparent.

Sources: [8] [9]

Test example: same mean value, different dataset

The following example is not an R-test. A report should contain the four samples A01 to A04. As an example rule: A complete report requires four valid measurements with unique IDs. The values are 98, 100, 102 and 100 in the same defined unit. Their mean value is 400 / 4 = 100.

In the event of a missing value for A04, the data point is absent. If only valid values are averaged, the result again yields 300 / 3 = 100. The identical mean value cannot mask the absence of one sample. The pre-defined target now requires the case to be flagged as incomplete: four samples expected, three valid, one value missing. No conclusion regarding actual product quality can be drawn from this.

Each table case begins with a copy of the defined starting inventory. After the case, revert the input and parameters. This ensures that a previous change does not obscure a subsequent error. The set values were independently recalculated; a actual production run must subsequently be documented together with its observed results.

Expected results for checking completeness alongside the mean
CaseInput / ModificationIndependently established expected resultExpected process decision
Normal case A01–A04: 98; 100; 102; 100 4 valid; Total 400; Mean value 100 Four-sample rule is satisfied
Missing value A04 without measurement value 3 valid; 1 missing; valid total 300; valid mean value 100 Label as incomplete report
Duplicate ID A03 is reassigned to A02; values remain unchanged A02 appears twice, A03 is missing; mean value remains 100 Investigate identity errors; no standard release.
Incorrect data type A04 contains the text open No valid numeric value for A04 Reject or clarify upon import rules return
Repetition Re-evaluate the unchanged normal inventory again Again 4 valid and mean value 100 Compare results and current status used

Sources: [6] [5] [8]

Specify the comparison deliberately for randomization procedures

Bootstrapping, simulation-based approaches, or other stochastic methods require additional specifications. R provides set.seed for defining an initial seed value, as well as RNGkind and RNGversion for selecting the random number generator parameters. A preserved seed is therefore a valuable component of a reproducible run, but it does not constitute evidence of the methodological appropriateness of the procedure.

Define what the repetition is intended to demonstrate. Should the same controlled run produce the same output, or should a statistical property be assessed within predefined limits? These questions are not interchangeable. Document the method used, relevant parameters, and the comparison criterion prior to evaluating an observed result.

Do not claim a general result identity between any package stands, computers or execution variants. If such conditions change, examine their meaning for the specific algorithm. A plausible-looking diagram and a stored start value are not sufficient.

Sources: [6] [8]

Maintain the relationship between input and decision-making

For a decision-relevant evaluation, it should remain evident which data led to a specific result, including the associated code and parameters. Chapter 4 requires structured documentation; for electronic records, the raw data volume must be defined. A finished PDF may represent part of the evaluation but does not automatically preserve the complete professional context.

sessionInfo provides information on R, platform, loaded packages, and other session characteristics. This is useful, but does not constitute an immutable archive. The documentation even specifies a limit regarding concurrent package installations. Therefore, supplement the session report with the inputs required for your analysis, script versions, and evaluated results.

Control who may modify data, code, and released reports, and ensure that allowable corrections remain traceable. An R-protocol is not automatically a complete regulatory audit trail. Assess required controls along the actual documentation process. Access control, traceable changes, and recovery must be consistent within the selected environment.

Sources: [9] [5] [8]

Further reading:

Review the affected analyses for updates

A new R version, package update, changed import file or different operating computer can affect an analysis. Identify affected functions and data paths. An unused new feature may have a different impact from a change to the calculation the team relies on.

Select relevant repetitions and complementary cases. For the mean value example, particularly pertinent anchor cases would include completeness, outlier handling, and result assignment. A comparison of previous reports can be helpful, but does not replace the need to evaluate new error pathways. A blanket revalidation after each package update cannot be inferred from this approach.

Also verify the return to a required previous version. A lock file alone is insufficient if required binary packages or external prerequisites are missing. Justify which components are retained and how historical evaluations remain readable. Restoring the software and maintaining a validated result are distinct objectives.

Sources: [4] [3] [8] [9]

Further reading:

What should be in place prior to startup

For initial engagement, you need a specific evaluation and a point of contact who can explain the meaning in the process. The checklist below supports the first meeting. Missing documentation will be visible as open tasks; it does not require replacement with a large volume of documents.

The department is responsible for the purpose and methodological suitability, the programming details including code and dependencies are explained, IT manages the operation, and QA integrates the process into the quality system. Effort arises primarily due to unknown script variants, multiple data sources, missing reference results, and unclear historical records. A workload assessment becomes more reliable once these factors are specifically defined.

  • Intended use, recipient of results, and potential consequences of errors to be specified.
  • Compile the R- inventory, packaging, and environment holdings with available stock.
  • Hold script levels, input structure, units, and error rules.
  • Prepare normal, boundary, and error data with independent setpoint values.
  • Assign responsibility for access, changes, result assessment and retention.
  • Restoration pathway as well as affected evaluations for updates to be determined.

Sources: [8] [9]

Project experience and collaboration

Link code, package versions and data in a reproducible analysis

For an analysis in R, we consider the code, package versions and underlying data together. With your team, we use reference cases to check how the expected results are produced and which versions were used. An established workflow may need targeted checks. In a new analysis environment, we first define its structure, change process and responsibilities. We include the report and sessionInfo in the evidence package and check what else is needed for a complete result record.

Frequently asked questions about R

Must every R-script within the company be validated?

No. The extent to which an R script must be validated depends on its actual usage. If the analysis supports GMP-related activities or decisions, its suitability for such purposes must be demonstrated. When assessing this, consider any downstream exports that may be used. A purely exploratory analysis serves a different purpose than a regularly used quality report. Explicitly describe the transition from such an initial non-binding investigation to a decision-critical application, to ensure that an originally non-binding study is not inadvertently elevated to a decision-relevant use.

Sources: [8]

Has R been validated by the R Foundation or the FDA?

The document "R: Regulatory Compliance and Validation Issues" from the R Foundation (as of March 12, 2026) outlines Base R and the Recommended Packages for regulated clinical study environments. It is neither a FDA approval nor a validation of your specific application. Use it as a limited supplier justification; additional packages, custom scripts, data, and operating conditions require separate and appropriate evaluation.

Sources: [2] [8]

Which R-packages should be included in the scope of validation?

Capture the actually used packages and relevant dependencies. Then map which functions impact the evaluation and which developer documentation supports them. It is neither appropriate to merely record the visible main package name, nor to comprehensively and indiscriminately review all available functions without justification. Library paths and versions help unambiguously determine the actual runtime environment.

Sources: [3] [2] [8]

Is the environment capable of providing a reproducible and validated setting?

R itself, external tools and operating system dependencies remain to be considered separately. Also check the input data, the code and the professional expectation. Whether a recovery works shows the intended recovery attempt under your conditions; the existence of a lock file alone does not prove this.

Sources: [4]

Can an evaluation of missing values be performed by setting na.rm = TRUE?

This may be appropriate for a defined method, but it must be substantiated technically. The function does not determine whether the remaining data are sufficient for your intended use. In the example of this article, three and four valid measurements yield the same mean value. Therefore, the expected number of values, the values used, and the exclusions should be evaluated together. The technical option neither replaces a completeness check nor a method decision.

Sources: [6] [8]

How do you verify a script whose statistics are too complex to calculate by hand?

Select an appropriate independent expectation: for example, a justified reference dataset, known properties, or a transparent comparison method. Subject the statistical validity to professional assessment. Additionally, verify simpler transitions such as import, filtering, and result assignment. A complex procedure does not render these individual checks obsolete; it merely justifies the absence of a simple comparison between two identical implementations.

Sources: [8]

Is a stored seed sufficient for replication?

A seed maintains a key parameter. Additionally, generator, method, package settings, and execution conditions may be relevant. Prior to execution, define the expected level of agreement and determine which deviations are technically acceptable. A repeatable value may still arise from an inappropriate method or incomplete input. Therefore, repeatability is one of several objectives to be demonstrated.

Sources: [6]

Should the PDF report and session info be retained?

sessionInfo describes components of the R environment; a PDF displays selected results. Additional inputs, script version, parameters, relevant corrections, and the evaluation decision may be required for subsequent assessment. Based on your evaluation, determine which components should be retained together. Review their readability and alignment over the required time period, rather than treating the two files as complete records without scrutiny.

Sources: [9] [5] [8]

Who must work together in a small company?

You require technical methodological competence, understanding of the script, knowledge of the operating procedures, and a quality assurance perspective. These responsibilities may be assigned to a small number of qualified individuals; one person does not need to perform all roles. Specifically agree on who defines acceptance criteria, evaluates deviations, and authorizes changes for use. External support does not substitute for knowledge of the internal process.

Sources: [8]

What determines the effort and duration of an R-validation?

Key factors include the number of actually used evaluation variants, data quality, dependencies, and available reference documentation. A clearly defined routine evaluation process must be treated differently from a portfolio of evolving scripts and package versions. Start with a comprehensive inventory and a representative workflow. Only from this foundation can work packages and stakeholder involvement be derived, without making blanket time or cost commitments.

Sources: [3] [8]

Sources and review date

As of 6 October 2026. Technical reference: R 4.6.1, Foundation Document dated 12 March 2026 and renv Documentation 1.3.1. Additional packages and specific operating environments require corresponding standalone documentation. Regulatory scope example: Human medicinal product-GMP. Tables and invoices are standalone support documents and do not constitute completed product testing.

  1. The R Project for Statistical Computing
  2. R: Regulatory Compliance and Validation Issues — A Guidance Document for the Use of R in Regulated Clinical Trial Environments
  3. R Installation and Administration
  4. Introduction to renv
  5. The R Utils Package — Data Input / Collect Information About the Current R Session
  6. The R Base Package — Random Number Generation / Arithmetic Mean
  7. European Commission: EudraLex Volume 4, Human Medicinal Products - GMP
  8. EU GMP Annex 11: Computerised Systems, January 2011 revision
  9. EU GMP Chapter 4: Documentation, January 2011 revision

Sources checked: .

Daniel Herrmann, Daniel Herrmann Consulting

Daniel Herrmann Consulting

Your R-Review purposefully evaluate

We assist you in defining the relevant analysis scope, categorizing existing documentation, and preparing traceable reviews for data, scripts, and operations.

  • Computer system validation →

    Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

Send a project enquiry Customer testimonials →